Wells Fargo & Company »

Spero Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $784 533 1.47
2023-09-30 $622 515 1.21
2023-06-30 $766 529 1.45
2022-12-31 $706 408 1.73
2022-09-30 $0 403 0.00
2022-06-30 $0 891 0.00
2022-03-31 $124k 14k 8.71
2021-12-31 $363k 23k 16.00
2021-09-30 $144k 7.8k 18.53
2021-06-30 $562k 40k 14.09
2021-03-31 $265k 18k 14.78
2020-12-31 $811k 42k 19.41
2020-09-30 $373k 33k 11.19
2020-06-30 $503k 37k 13.53
2020-03-31 $216k 27k 8.05
2019-12-31 $189k 20k 9.62
2019-09-30 $182k 17k 10.56
2019-06-30 $157k 14k 11.51
2019-03-31 $61k 4.7k 12.86
2018-12-31 $88k 14k 6.18
2018-09-30 $25k 2.3k 10.49
2018-06-30 $12k 817 14.69
2018-03-31 $16k 1.1k 14.69
2017-12-31 $11k 990 11.24